These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35849806)

  • 1. Anesthetic Management of a Patient With Catecholaminergic Polymorphic Ventricular Tachycardia.
    Shionoya Y; Hirayama K; Saito K; Kawasaki E; Kantake Y; Okamoto H; Goi T; Sunada K; Nakamura K
    Anesth Prog; 2022 Jun; 69(2):24-29. PubMed ID: 35849806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.
    Priori SG; Napolitano C; Memmi M; Colombi B; Drago F; Gasparini M; DeSimone L; Coltorti F; Bloise R; Keegan R; Cruz Filho FE; Vignati G; Benatar A; DeLogu A
    Circulation; 2002 Jul; 106(1):69-74. PubMed ID: 12093772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report.
    Seidlmayer LK; Riediger F; Pagonas N; Nordbeck P; Ritter O; Sasko B
    J Med Case Rep; 2018 Oct; 12(1):298. PubMed ID: 30296944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anesthetic Management for Dental Extraction in a Patient With Catecholaminergic Polymorphic Ventricular Tachycardia Syndrome: A Case Report.
    Wang E; Trinh VN; Bachar BJ; Nagm H
    Cureus; 2023 Oct; 15(10):e47224. PubMed ID: 38021671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Catecholaminergic polymorphic ventricular tachycardia; possible diagnosis in cases of syncope and sudden death of family members].
    Lieve KV; Wilde AA; van der Werf C
    Ned Tijdschr Geneeskd; 2015; 159():A8205. PubMed ID: 25650029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia with a mutant of RYR2 at c.7580T>G for 6 years in a 9-year-old child.
    Duan H; Lu Y; Yan S; Qiao L; Hua Y; Li Y; Zhou K; Wang C
    Medicine (Baltimore); 2018 Apr; 97(16):e0368. PubMed ID: 29668588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burst Exercise Testing Can Unmask Arrhythmias in Patients With Incompletely Penetrant Catecholaminergic Polymorphic Ventricular Tachycardia.
    Roston TM; Kallas D; Davies B; Franciosi S; De Souza AM; Laksman ZW; Sanatani S; Krahn AD
    JACC Clin Electrophysiol; 2021 Apr; 7(4):437-441. PubMed ID: 33888264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient ventricular bigeminy during emergence from general anesthesia in a pediatric patient with catecholaminergic polymorphic ventricular tachycardia.
    Matsumura T; Hosokawa S; Hanaoka M; Abe Y; Iwamoto T; Maeda S
    J Electrocardiol; 2022; 73():38-41. PubMed ID: 35617895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise testing oversights underlie missed and delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia in young sudden cardiac arrest survivors.
    Giudicessi JR; Ackerman MJ
    Heart Rhythm; 2019 Aug; 16(8):1232-1239. PubMed ID: 30763784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical challenges in the management of catecholaminergic polymorphic ventricular tachycardia in children].
    Ge HY; Li XM; Jiang H; Zhang Y; Liu HJ; Zheng XC; Li MT
    Zhonghua Er Ke Za Zhi; 2017 Dec; 55(12):926-931. PubMed ID: 29262473
    [No Abstract]   [Full Text] [Related]  

  • 12. Catecholaminergic polymorphic ventricular tachycardia.
    Liu N; Colombi B; Raytcheva-Buono EV; Bloise R; Priori SG
    Herz; 2007 May; 32(3):212-7. PubMed ID: 17497254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of catecholaminergic polymorphic ventricular tachycardia.
    Lee SY; Kim JB; Im E; Yang WI; Joung B; Lee MH; Kim SS
    Yonsei Med J; 2009 Jun; 50(3):448-51. PubMed ID: 19568611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia.
    Watanabe H; van der Werf C; Roses-Noguer F; Adler A; Sumitomo N; Veltmann C; Rosso R; Bhuiyan ZA; Bikker H; Kannankeril PJ; Horie M; Minamino T; Viskin S; Knollmann BC; Till J; Wilde AA
    Heart Rhythm; 2013 Apr; 10(4):542-7. PubMed ID: 23286974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plakophilin-2 Truncation Variants in Patients Clinically Diagnosed With Catecholaminergic Polymorphic Ventricular Tachycardia and Decedents With Exercise-Associated Autopsy Negative Sudden Unexplained Death in the Young.
    Tester DJ; Ackerman JP; Giudicessi JR; Ackerman NC; Cerrone M; Delmar M; Ackerman MJ
    JACC Clin Electrophysiol; 2019 Jan; 5(1):120-127. PubMed ID: 30678776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BASIC AND CLINICAL INSIGHTS IN CATECHOLAMINERGIC (FAMILIAL) POLYMORPHIC VENTRICULAR TACHYCARDIA.
    Márquez MF; Totomoch-Serra A; Rueda A; Avelino-Cruz JE; Gallegos-Cortez A
    Rev Invest Clin; 2019; 71(4):226-236. PubMed ID: 31448784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anesthetic management of a child with catecholaminergic polymorphic ventricular tachycardia undergoing insertion of implantable cardioverter defibrillator : a case report.
    Omiya K; Mitsui K; Matsukawa T
    JA Clin Rep; 2020 Feb; 6(1):16. PubMed ID: 32103353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catecholaminergic polymorphic ventricular tachycardia.
    Liu N; Ruan Y; Priori SG
    Prog Cardiovasc Dis; 2008; 51(1):23-30. PubMed ID: 18634915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death.
    Sumitomo N; Harada K; Nagashima M; Yasuda T; Nakamura Y; Aragaki Y; Saito A; Kurosaki K; Jouo K; Koujiro M; Konishi S; Matsuoka S; Oono T; Hayakawa S; Miura M; Ushinohama H; Shibata T; Niimura I
    Heart; 2003 Jan; 89(1):66-70. PubMed ID: 12482795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia.
    Khoury A; Marai I; Suleiman M; Blich M; Lorber A; Gepstein L; Boulos M
    Heart Rhythm; 2013 Nov; 10(11):1671-5. PubMed ID: 23954267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.